Task: Answer the multiple-choice question.
Query: Which drug exhibits a 14.419\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCCNC(=O)CC1C(=O)N(Cc2ccccc2)C(C)c2nc3ccccc3n21
b: Cc1cc(N2CCCCC2)nc2c(C)cccc12
c: CCOC(=O)C1(c2ccccc2)CCN(CC(=O)Nc2ccc(C)cc2)CC1
Answer: a. CCCNC(=O)CC1C(=O)N(Cc2ccccc2)C(C)c2nc3ccccc3n21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)CC1C(=O)N(Cc2ccccc2)C(C)c2nc3ccccc3n21
CCCNC(=O)CC1C(=O)N(Cc2ccccc2)C(C)c2nc3ccccc3n21
2-(2-benzyl-1-methyl-3-oxo-1,4-dihydropyrazino[1,2-a]benzimidazol-4-yl)-N-propylacetamide